Technologies
Researchers applied MIGHT to liquid biopsy data, focusing on ccfDNA fragmentation patterns (e.g., fragment lengths, positions, and end motifs) to determine which features reliably indicate cancer: Challenge: False Positives Linked…
OncoFirm Diagnostics | https://oncofirmdiagnostics.com 1. Executive Summary The intersection of artificial intelligence (AI) and biomarker science is revolutionizing early cancer detection. By leveraging AI algorithms to analyze complex biological signals, OncoFirm…
Fluorescent LFA vs Traditional Testing
OncoFirm Diagnostics | https://oncofirmdiagnostics.com 1. Executive Summary Early detection of cancer remains one of the most cost-effective, life-saving interventions in modern medicine. However, millions globally still lack access to timely,…
AI-Driven Biomarkers: Transforming Cancer Detection Through Multimodal Intelligence Introduction The integration of artificial intelligence (AI) into healthcare has revolutionized biomedical research, diagnostics, and patient care. One of the most promising…
RNA Polymerase II Levels in Histone Genes: A Predictive Biomarker for Tumor Aggressiveness and Recurrence Introduction Histone genes play a fundamental role in DNA packaging and chromatin structure, and their…
OncoFirm™ Electronic Reader cassette reader* (detailed information coming soon)… Cutting-Edge Digital Cancer Diagnostics Solutions Lateral Flow Electronic Reader (LFER) technology is an advanced diagnostic tool used to enhance and quantify…
The Thomsen–Friedenreich (TF) antigen, also known as CD176, is a disaccharide structure comprising galactose and N-acetylgalactosamine (Galβ1-3GalNAcα1-Ser/Thr). It serves as the core 1 structure in O-linked glycosylation of proteins. In…